Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayer

Showing results (321-330 of 528) with videos related to

Pageof 53
Sort By:
Antimicrobial Agents and Chemotherapy|December 24, 2004
Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis modelYan Q Xiong, Julie Willard, Jagath L Kadurugamuwa, et al.
Infection and Immunity|October 1, 1992
Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosaA S Bayer, S Park, M C Ramos, et al.
Human Genetics|November 1, 1996
Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesL Kluwe, S Bayer, M E Baser, et al.
Radiology|June 1, 1996
HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo timesJ Laubenberger, D Häussinger, S Bayer, et al.
The Journal of Infectious Diseases|December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypesPamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesArnold S Bayer, Nagendra N Mishra, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Soo-Jin Yang, Yan Q Xiong, Susan Boyle-Vavra, et al.
Archives of Internal Medicine|April 1, 1987
Solid-phase radioimmunoassay for IgG antibodies to Staphylococcus epidermidis. Use in serious coagulase-negative staphylococcal infectionsF Espersen, L J Wheat, A T Bemis, et al.
Pharmaceutics|October 17, 2019
Evaluation of Drug Delivery and Efficacy of Ciprofloxacin-Loaded Povidone Foils and Nanofiber Mats in a Wound-Infection Model Based on Ex Vivo Human SkinFiorenza Rancan, Marco Contardi, Jana Jurisch, et al.
Chemotherapy|January 1, 1983
Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillinC Choi, A S Bayer, N K Fujita, et al.
Pageof 53

Showing results (321-330 of 528) with videos related to

Sort By:
Pageof 53
Antimicrobial Agents and Chemotherapy|December 24, 2004
Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis modelYan Q Xiong, Julie Willard, Jagath L Kadurugamuwa, et al.
Infection and Immunity|October 1, 1992
Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosaA S Bayer, S Park, M C Ramos, et al.
Human Genetics|November 1, 1996
Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypesL Kluwe, S Bayer, M E Baser, et al.
Radiology|June 1, 1996
HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo timesJ Laubenberger, D Häussinger, S Bayer, et al.
The Journal of Infectious Diseases|December 17, 2009
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypesPamela A Moise, Alan Forrest, Arnold S Bayer, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesArnold S Bayer, Nagendra N Mishra, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|June 16, 2010
Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")Soo-Jin Yang, Yan Q Xiong, Susan Boyle-Vavra, et al.
Archives of Internal Medicine|April 1, 1987
Solid-phase radioimmunoassay for IgG antibodies to Staphylococcus epidermidis. Use in serious coagulase-negative staphylococcal infectionsF Espersen, L J Wheat, A T Bemis, et al.
Pharmaceutics|October 17, 2019
Evaluation of Drug Delivery and Efficacy of Ciprofloxacin-Loaded Povidone Foils and Nanofiber Mats in a Wound-Infection Model Based on Ex Vivo Human SkinFiorenza Rancan, Marco Contardi, Jana Jurisch, et al.
Chemotherapy|January 1, 1983
Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillinC Choi, A S Bayer, N K Fujita, et al.
Pageof 53